News
PCSA
2.260
+1.80%
0.040
PROCESSA PHARMACEUTICALS NAMES DR. STEVEN CHA SENIOR VICE PRESIDENT OF CLINICAL RESEARCH
Reuters · 3d ago
Weekly Report: what happened at PCSA last week (0422-0426)?
Weekly Report · 4d ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Aon plc shares fell 7.4% to $283.19 on Friday. The company reported worse-than-expected quarterly financial results. Biodexa Pharmaceuticals Plc shares jumped 73.3% after the company signed a deal with eRapa. Snap Inc. Shares jumped 23% in the mid-day session.
Benzinga · 6d ago
Applied Dna Sciences, OptimizeRx, SCWorx among healthcare movers
Seeking Alpha · 6d ago
HTZ, CYCC and WORX among pre-market losers
On the Move HTZ, CYCC and WORX among pre-market losers. ReAlpha Tech Corp. (AIRE) and Boyd Gaming Corp (BYD) among losers. ACM Research announces preliminary unaudited revenue and shipments for the first quarter of 2024.
Seeking Alpha · 6d ago
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. Rose sharply in today's pre-market trading. The company reported upbeat results for its first quarter. Tevogen Bio Holdings Inc. Shares gained 64.7% after falling over 43% on Thursday. Skechers U.S.A., Inc. And Snap Inc. Also rose in pre- market trading.
Benzinga · 04/26 12:18
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. Cryo-Cell International (AMEX:CCEL) shares increased by 27.94% during the session. Fresh2 Group shares moved upwards by 18.33%.
Benzinga · 04/26 12:06
HC Wainwright & Co. Initiates Coverage of Processa Pharmaceuticals (PCSA) with Buy Recommendation
NASDAQ · 04/26 01:38
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
U.S. Stocks traded lower toward the end of trading on Thursday. The Dow traded down 1.20% while the Nasdaq Composite fell by around 100 points. Bristol Myers Squibb & Co. Shares fell more than 8% after posting a loss in the first quarter. Impinj, Inc. Shares shot up 26% after reporting better-than-expected first-quarter financial results. Asian markets closed mostly higher in Asia Pacific markets.
Benzinga · 04/25 18:32
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. Fell 6.6% to $339.37 on Thursday. Caterpillar reported better-than-expected first-quarter EPS but missed revenue estimates. Barfresh Food Group, Inc. Shares surged 87.2% after the company reported better than expected results. Chicken Soup for the Entertainment for the Soul Entertainment dropped 75%.
Benzinga · 04/25 17:57
BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel
U.S. Stocks slumped on Thursday. Dow Jones Industrial Average was down 1.15% and the S&P 500 was down 0.76%. Most megacaps fell after Meta Platforms' quarterly results. Newmont Corp. Was the top percentage gainer on the NYSE and the Nasdaq.
Reuters · 04/25 17:55
CETX, ATNI and MNY among mid-day movers
On the Move CETX, ATNI and MNY among mid-day movers. Loar Holdings and Safe & Green Holdings Corp are among the Gainers. E-Home Household Service Holdings Ltd. Is one of the losers in the SA market.
Seeking Alpha · 04/25 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. Akso Health Group ( NASDAQ:AHG) shares increased by 29.87%. Processa Pharma (NASdaq:PCSA) stock increased by 43.18%. Cyclacel Pharmaceuticals stock declined by 33.1% during the session.
Benzinga · 04/25 16:31
BUZZ-U.S. STOCKS ON THE MOVE-Viking, Alphabet, Dover
U.S. Stocks were sharply lower on Thursday. The Dow Jones Industrial Average was down 1.58% and the S&P 500 and Nasdaq Composite were also down. Meta Platforms dropped 12.7% after dour quarterly results. Newmont Corp was the top percentage gainer on the S.P. 500 and the Nasdaq.
Reuters · 04/25 16:18
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
U.S. Stocks traded lower midway through trading on Thursday. The Dow traded down 1.55% and the Nasdaq Composite fell 1.60%. Merck & Co., Inc. Reported better-than-expected first-quarter financial results. Impinj, Inc. Shares shot up 17% after reporting better- than-expected results. Asian markets closed mostly higher on Thursday but European shares were mostly lower.
Benzinga · 04/25 16:04
Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers
Healthcare On the Move: Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers. S&P 500 Health Care Sector -0.23% to 1637.36. Pharmaceuticals and Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/25 14:00
Dow Dips Over 500 Points; US GDP Growth Misses Expectations
The Dow Jones index fell more than 500 points on Thursday. The U.S. Economy grew an annualized 1.6% in the first quarter. Consumer staples shares climbed by 0.3% while communication services shares fell by 6.3%. The Dow traded down 1.42% and the NASDAQ fell 2.16%. Asian markets closed mostly higher on Thursday in Asia Pacific markets.
Benzinga · 04/25 13:47
POET, PCSA and BRFH are among premarket gainers
On the Move POET, PCSA and BRFH are among premarket gainers. Barfresh Food Group (NASDAQ:BRFH) and Cyclacel Pharmaceuticals (CYCC) are among the day's top premarket losers. American Airlines Group (AAL) and Unilever (UL) are also on the list.
Seeking Alpha · 04/25 12:20
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Processa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. Cyclacel Pharmaceuticals stock rose 23.04% and Compass Therapeutics shares rose 21.62%. Can Fite Biofarma (AMEX:CANF) stock also moved upwards.
Benzinga · 04/25 12:06
Processa Pharmaceuticals Price Target Announced at $8.00/Share by HC Wainwright & Co.
Dow Jones · 04/25 10:49
More
Webull provides a variety of real-time PCSA stock news. You can receive the latest news about Processa Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About PCSA
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on utilizing its regulatory science approach, including the principles associated with food and drug administration (FDA’s) Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (NGC) oncology drug products. The three NGC treatments in its pipeline are NGC-Capecitabine (NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem) and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri). NGC-Cap is a combination of PCS6422 and capecitabine, capecitabine being the oral prodrug of the cancer drug 5-fluorouracil. PCS3117 is an oral analog of gemcitabine that is converted to its active metabolite by a different enzyme system than gemcitabine, resulting in a positive response in gemcitabine patients and some gemcitabine treatment-resistant patients. PCS11T is a prodrug of the active metabolite of irinotecan (SN-38).